XML 38 R21.htm IDEA: XBRL DOCUMENT

Subsequent Events	12 Months Ended
Subsequent Events	Dec. 31, 2017
Subsequent Events [Abstract]
Subsequent Events	15. Subsequent Events On February 27, 2018 the Company closed the Restructuring Transaction describe in Note 10 and issued 91,815,517 shares of common stock in exchange for extinguishment of all outstanding term loans, accrued interest and fees totaling $18.4 million and received cash proceeds of $1.5 million. In addition, all of the Company’s assets related to benznidazole were transferred to a new joint venture entity as contemplated in the Restructuring Transactions. On March 12, 2018, the Company issued 2,445,557 shares of its common stock for total proceeds of $1.1 million to accredited investors.